Paul Tudor Jones Ani Pharmaceuticals Inc Transaction History

Tudor Investment Corp Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $177,431 - $222,630	-6,726 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $290,710 - $486,621	-9,713 Reduced 59.09%	6,726 $218,000
Q1 2020 May 15, 2020	BUY	$30.35 - $67.14 $293,211 - $648,639	9,661 Added 142.53%	16,439 $670,000
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $28,993 - $41,591	-521 Reduced 7.14%	6,778 $418,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $472,245 - $623,261	7,299 New	7,299 $532,000

212

18.9M

11.7K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.03B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.